Home  >  Products  >  B3gnt7 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 ) Blocking Peptide (the middle region of B3gnt7)(100ug)
B3gnt7 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 ) Blocking Peptide (the middle region of B3gnt7)(100ug)

B3gnt7 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 ) Blocking Peptide (the middle region of B3gnt7)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-B3gnt7 Antibody (ARP49028_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP49028
Size: 100ug
Weight: 45kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: B3gnt7 may be involved in keratane sulfate biosynthesis and transfers N-acetylgalactosamine on to keratan sulfate-related glycans. B3gnt7 may play a role in preventing cells from migrating out of the original tissues and invading surrounding tissues.
Alternative names: C330001H22Rik; beta-3GnT7
See Full Product Listings >